Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Loxo Oncology begins Phase I study of TRK inhibitor
The Phase 1 study has been designed to assess the safety, pharmacokinetics and pharmacodynamics of escalating doses of LOXO-101. In a second stage, it will also provide a
The Phase 1 study has been designed to assess the safety, pharmacokinetics and pharmacodynamics of escalating doses of LOXO-101. In a second stage, it will also provide a
Financial terms of the agreement were not disclosed by the two companies. Pursuant to the terms of the agreement, Sofgen Pharmaceuticals will be responsible for development, manufacturing and
TRV130 is a small molecule G protein biased ligand at the mu opioid receptor. Phase IIa/b study is a multicenter, randomized trial designed to assess the effects of
The Phase I study is Complexa’s first human clinical trial designed to assess the safety and pharmacokinetics of its CXA-10. With the use of various biomarkers, this study
Purixan is a 20mg/ml oral suspension of existing ALL treatment mercaptopurine. Prior to Xaluprine and Purixan, mercaptopurine has only been available as a 50mg tablet for many years.
ADXS-HPV is Advaxis’ lead immunotherapy drug candidate designed to target cells expressing the HPV gene E7. Expression of the E7 gene from high-risk HPV variants is responsible for
According to Allergan, the Irish Medicines Board’s positive opinion an important step towards securing national licenses in the 14 European countries involved in the MRP and marks a
Grupo Ferrer Internacional (Ferrer) is commercializing ADASUVE in the Nordic countries via a distribution agreement with Medivir. Ferrer is Alexza’s commercial partner for ADASUVE in the Europe, Latin
It is indicated for the treatment of excess visceral adipose tissue, as evaluated by waist circumference = 95 cm for men and = 94 cm for women, and
MEDIWIET is a Dutch organization of patients using medicinal cannabis based medication. Main aim of the trial is to further advance the knowledge of cannabis plant based product